Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 19/20 | 0.66 |
| ▸ | CCND1 | P24385 | 15/20 | 0.66 |
| ▸ | CDK1 | P06493 | 14/20 | 0.66 |
| ▸ | CDK4 | P11802 | 14/20 | 0.66 |
| ▸ | CDK6 | Q00534 | 3/20 | 0.56 |
| ▸ | CDK9 | P50750 | 2/20 | 0.56 |
| ▸ | CASK | O14936 | 1/20 | 0.56 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.56 |
| ▸ | CDKL5 | O76039 | 1/20 | 0.56 |
| ▸ | STK10 | O94804 | 1/20 | 0.56 |
| ▸ | CDK14 | O94921 | 1/20 | 0.56 |
| ▸ | ABL1 | P00519 | 1/20 | 0.56 |
| ▸ | EGFR | P00533 | 1/20 | 0.56 |
| ▸ | MAK | P20794 | 1/20 | 0.56 |
| ▸ | CDK11B | P21127 | 1/20 | 0.56 |
| ▸ | TTK | P33981 | 1/20 | 0.56 |
| ▸ | CLK1 | P49759 | 1/20 | 0.56 |
| ▸ | CLK2 | P49760 | 1/20 | 0.56 |
| ▸ | CLK3 | P49761 | 1/20 | 0.56 |
| ▸ | GSK3A | P49840 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3519637 | 0.90 | CDK2 (0.75) | CDK2CCND1CDK1CDK4CDK6 | |
| SCHEMBL3518107 | 0.85 | CDK2 (0.82) | CDK2CCND1CDK1CDK4CDK6 | |
| SCHEMBL3521308 | 0.84 | CDK2 (0.61) | CDK2CCND1CDK1CDK4CDK6 | |
| SCHEMBL4350211 | 0.81 | CDK1 (0.82) | CDK2CCND1CDK1CDK4CDK6 | |
| SCHEMBL4361250 | 0.81 | CDK2 (0.70) | CDK2CCND1CDK1CDK4CDK6 | |
| SCHEMBL4350749 | 0.80 | CDK2 (0.73) | CDK2CCND1CDK1CDK4CDK6 | |
| SCHEMBL4352663 | 0.80 | CDK2 (0.75) | CDK2CCND1CDK1CDK4CDK6 | |
| SCHEMBL4352519 | 0.80 | CDK1 (1.00) | CDK2CCND1CDK1CDK4CDK6 | |
| SCHEMBL3520103 | 0.80 | CDK2 (0.68) | CDK2CCND1CDK1CDK4CDK6 | |
| SCHEMBL14723340 | 0.80 | CDK1 (0.71) | CDK2CCND1CDK1CDK4CDK6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7705009-B2 | 4-aminopyrimidine-5-thione derivatives | HOFFMAN-LA ROCHE INC. (US) | 2010-04-27 | — | — | US | claimed |
| US-20070117821-A1 | 4-Aminopyrimidine-5-thione derivatives | DING QINGJIE | 2007-05-24 | — | — | US | claimed |
| US-7705009-B2 | 4-aminopyrimidine-5-thione derivatives | HOFFMAN-LA ROCHE INC. (US) | 2010-04-27 | — | — | US | disclosed |
| US-7705009-B2 | 4-aminopyrimidine-5-thione derivatives | HOFFMAN-LA ROCHE INC. (US) | 2010-04-27 | — | — | US | disclosed |
| US-7705009-B2 | 4-aminopyrimidine-5-thione derivatives | HOFFMAN-LA ROCHE INC. (US) | 2010-04-27 | — | — | US | disclosed |
| WO-2007060110-A1 | 4-AMINOPYRIMIDINE-5-THIONE-DERIVATIVES FOR THE TREATMENT OF CANCER | F. HOFFMANN-LA ROCHE AG (CH) | 2007-05-31 | — | — | WO | disclosed |
| US-20070117821-A1 | 4-Aminopyrimidine-5-thione derivatives | DING QINGJIE | 2007-05-24 | — | — | US | disclosed |
| US-20070117821-A1 | 4-Aminopyrimidine-5-thione derivatives | DING QINGJIE | 2007-05-24 | — | — | US | disclosed |
| US-20070117821-A1 | 4-Aminopyrimidine-5-thione derivatives | DING QINGJIE | 2007-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070117821-A1 | 4-Aminopyrimidine-5-thione derivatives | CDK4, CDK1, CDK2 | CDK2 3/4885CCND1 40/4885CDK1 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.